Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00892151 · ClinicalTrials.gov registry record · NA
Evaluation of GLUCOFACTS® Deluxe Diabetes Management System
A NA study, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT00892151: Completed NA study, sponsored by Ascensia Diabetes Care.
NCT00892151 is a NA study that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00892151, a NA study, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate a Diabetes management program in the hands of potential users, both health care professionals and lay persons.
Primary Outcome
Study staff rated participants on their success at perfoming specific tasks. The rating scale was: 1. = Successful 2. = Successful after being referred to user instructions 3. = Successful with verbal assistance or review of part of user instructions (Similar to review of a specific function during a Customer Service call.) 4. = Unsuccessful (Incorrectly performed part of the testing regimen or required intervention by study staff.) 5. = Problem encountered with software
Interventions
- DEVICE GLUCOFACTS® Deluxe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-04 |
| Phase | NA |
What the finished NCT00892151 record still lists
NCT00892151 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which GLUCOFACTS® Deluxe is the first listed.
NCT00892151 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00892151 about?
NCT00892151 is a clinical study titled "Evaluation of GLUCOFACTS® Deluxe Diabetes Management System". The purpose of this study is to evaluate a Diabetes management program in the hands of potential users, both health care professionals and lay persons.
What is the current status of trial NCT00892151?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2009-04. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00892151?
The interventions under investigation include: GLUCOFACTS® Deluxe (DEVICE).
Who is sponsoring clinical trial NCT00892151?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00892151's enrollment target sits among peer trials
51 1279th of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia